Pharmaceutical Intermediate Market Report

Europe Pharmaceutical Intermediate Market Size, Status and Forecast 2014-2026

  • POSTDATE：Nov 28, 2019
  • PAGES：179
  • REPORT CODE：GMM397936
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Pharmaceutical Intermediate market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 10.6% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Pharmaceutical Intermediate Market Segmentations:

    By Player:

    • Arkema

    • Arlife Sciences

    • Kangda Chem

    • Dishman Group

    • Lianhe Tech

    • FST Pharma

    • Aceto

    • Interchem

    • Codexis

    • Eastar Chem

    • BASF

    • Midas Pharma

    • Ganesh Group

    • Wintersun Chem

    By Type:

    • Type 1

    • Type 2

    • Type 3

    By End-User:

    • End-User 1

    • End-User 2

    • End-User 3

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Pharmaceutical Intermediate Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Pharmaceutical Intermediate Market Size and Growth Rate of Type 1 from 2014 to 2026

    • 1.3.2 Europe Pharmaceutical Intermediate Market Size and Growth Rate of Type 2 from 2014 to 2026

    • 1.3.3 Europe Pharmaceutical Intermediate Market Size and Growth Rate of Type 3 from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Pharmaceutical Intermediate Market Size and Growth Rate of End-User 1 from 2014 to 2026

    • 1.4.2 Europe Pharmaceutical Intermediate Market Size and Growth Rate of End-User 2 from 2014 to 2026

    • 1.4.3 Europe Pharmaceutical Intermediate Market Size and Growth Rate of End-User 3 from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Pharmaceutical Intermediate Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Pharmaceutical Intermediate Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Pharmaceutical Intermediate Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Pharmaceutical Intermediate Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Pharmaceutical Intermediate Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Pharmaceutical Intermediate Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Pharmaceutical Intermediate Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Pharmaceutical Intermediate Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Pharmaceutical Intermediate Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Intermediate Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Intermediate Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Intermediate Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Pharmaceutical Intermediate Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Pharmaceutical Intermediate by Major Types

      • 3.4.1 Market Size and Growth Rate of Type 1

      • 3.4.2 Market Size and Growth Rate of Type 2

      • 3.4.3 Market Size and Growth Rate of Type 3

    4 Segmentation of Pharmaceutical Intermediate Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Pharmaceutical Intermediate by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Pharmaceutical Intermediate for End-User 1

      • 4.4.2 Market Size and Growth Rate of Pharmaceutical Intermediate for End-User 2

      • 4.4.3 Market Size and Growth Rate of Pharmaceutical Intermediate for End-User 3

    5 Market Analysis by Major Regions

    • 5.1 Europe Pharmaceutical Intermediate Production Analysis by Top Regions

    • 5.2 Europe Pharmaceutical Intermediate Consumption Analysis by Top Regions

    • 5.3 Europe Pharmaceutical Intermediate Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Pharmaceutical Intermediate Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Pharmaceutical Intermediate Production, Import, Consumption and Export Analysis

      • 5.3.3 France Pharmaceutical Intermediate Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Pharmaceutical Intermediate Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Pharmaceutical Intermediate Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Pharmaceutical Intermediate Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Pharmaceutical Intermediate Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Pharmaceutical Intermediate Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Pharmaceutical Intermediate Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Intermediate Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Intermediate Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Intermediate Production, Import, Consumption and Export Analysis

    6 Product Circulation of Pharmaceutical Intermediate Market among Top Countries

    • 6.1 Top 5 Export Countries in Pharmaceutical Intermediate Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Pharmaceutical Intermediate Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Pharmaceutical Intermediate Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Pharmaceutical Intermediate Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Pharmaceutical Intermediate Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Pharmaceutical Intermediate Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Pharmaceutical Intermediate Landscape Analysis

    • 7.1 Germany Pharmaceutical Intermediate Landscape Analysis by Major Types

    • 7.2 Germany Pharmaceutical Intermediate Landscape Analysis by Major End-Users

    8. UK Pharmaceutical Intermediate Landscape Analysis

    • 8.1 UK Pharmaceutical Intermediate Landscape Analysis by Major Types

    • 8.2 UK Pharmaceutical Intermediate Landscape Analysis by Major End-Users

    9. France Pharmaceutical Intermediate Landscape Analysis

    • 9.1 France Pharmaceutical Intermediate Landscape Analysis by Major Types

    • 9.2 France Pharmaceutical Intermediate Landscape Analysis by Major End-Users

    10. Italy Pharmaceutical Intermediate Landscape Analysis

    • 10.1 Italy Pharmaceutical Intermediate Landscape Analysis by Major Types

    • 10.2 Italy Pharmaceutical Intermediate Landscape Analysis by Major End-Users

    11. Spain Pharmaceutical Intermediate Landscape Analysis

    • 11.1 Spain Pharmaceutical Intermediate Landscape Analysis by Major Types

    • 11.2 Spain Pharmaceutical Intermediate Landscape Analysis by Major End-Users

    12. Poland Pharmaceutical Intermediate Landscape Analysis

    • 12.1 Poland Pharmaceutical Intermediate Landscape Analysis by Major Types

    • 12.2 Poland Pharmaceutical Intermediate Landscape Analysis by Major End-Users

    13. Russia Pharmaceutical Intermediate Landscape Analysis

    • 13.1 Russia Pharmaceutical Intermediate Landscape Analysis by Major Types

    • 13.2 Russia Pharmaceutical Intermediate Landscape Analysis by Major End-Users

    14. Switzerland Pharmaceutical Intermediate Landscape Analysis

    • 14.1 Switzerland Pharmaceutical Intermediate Landscape Analysis by Major Types

    • 14.2 Switzerland Pharmaceutical Intermediate Landscape Analysis by Major End-Users

    15. Turkey Pharmaceutical Intermediate Landscape Analysis

    • 15.1 Turkey Pharmaceutical Intermediate Landscape Analysis by Major Types

    • 15.2 Turkey Pharmaceutical Intermediate Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Intermediate Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Intermediate Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Intermediate Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Intermediate Landscape Analysis by Top Countries

      • 16.3.1 Denmark Pharmaceutical Intermediate Market Volume and Growth Rate

      • 16.3.2 Finland Pharmaceutical Intermediate Market Volume and Growth Rate

      • 16.3.3 Norway Pharmaceutical Intermediate Market Volume and Growth Rate

      • 16.3.4 Sweden Pharmaceutical Intermediate Market Volume and Growth Rate

      • 16.3.6 Iceland Pharmaceutical Intermediate Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Intermediate Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Intermediate Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Intermediate Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Intermediate Landscape Analysis by Top Countries

      • 17.3.1 Belgium Pharmaceutical Intermediate Market Volume and Growth Rate

      • 17.3.2 Netherlands Pharmaceutical Intermediate Market Volume and Growth Rate

      • 17.3.3 Luxembourg Pharmaceutical Intermediate Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Intermediate Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Intermediate Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Intermediate Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Intermediate Landscape Analysis by Top Countries

      • 18.3.1 Estonia Pharmaceutical Intermediate Market Volume and Growth Rate

      • 18.3.2 Latvia Pharmaceutical Intermediate Market Volume and Growth Rate

      • 18.3.3 Lithuania Pharmaceutical Intermediate Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Arkema

      • 19.1.1 Arkema Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Arlife Sciences

      • 19.2.1 Arlife Sciences Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Kangda Chem

      • 19.3.1 Kangda Chem Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Dishman Group

      • 19.4.1 Dishman Group Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Lianhe Tech

      • 19.5.1 Lianhe Tech Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 FST Pharma

      • 19.6.1 FST Pharma Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Aceto

      • 19.7.1 Aceto Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Interchem

      • 19.8.1 Interchem Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Codexis

      • 19.9.1 Codexis Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Eastar Chem

      • 19.10.1 Eastar Chem Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 BASF

      • 19.11.1 BASF Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 Midas Pharma

      • 19.12.1 Midas Pharma Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 Ganesh Group

      • 19.13.1 Ganesh Group Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 Wintersun Chem

      • 19.14.1 Wintersun Chem Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    The List of Tables and Figures (Totals 86 Figures and 134 Tables)

    • Figure Product Picture

    • Figure Europe Pharmaceutical Intermediate Market Size and Growth Rate of Type 1 from 2014 to 2026

    • Figure Europe Pharmaceutical Intermediate Market Size and Growth Rate of Type 2 from 2014 to 2026

    • Figure Europe Pharmaceutical Intermediate Market Size and Growth Rate of Type 3 from 2014 to 2026

    • Figure Europe Pharmaceutical Intermediate Market Size and Growth Rate of End-User 1 from 2014 to 2026

    • Figure Europe Pharmaceutical Intermediate Market Size and Growth Rate of End-User 2 from 2014 to 2026

    • Figure Europe Pharmaceutical Intermediate Market Size and Growth Rate of End-User 3 from 2014 to 2026

    • Figure Germany Pharmaceutical Intermediate Market Size and Growth Rate from 2014 to 2026

    • Figure UK Pharmaceutical Intermediate Market Size and Growth Rate from 2014 to 2026

    • Figure France Pharmaceutical Intermediate Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Pharmaceutical Intermediate Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Pharmaceutical Intermediate Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Pharmaceutical Intermediate Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Pharmaceutical Intermediate Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Pharmaceutical Intermediate Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Pharmaceutical Intermediate Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Pharmaceutical Intermediate Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Pharmaceutical Intermediate Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Intermediate Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Pharmaceutical Intermediate Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Pharmaceutical Intermediate Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Pharmaceutical Intermediate Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Pharmaceutical Intermediate Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Pharmaceutical Intermediate Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Intermediate Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Pharmaceutical Intermediate Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Pharmaceutical Intermediate Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Pharmaceutical Intermediate Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Intermediate Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Pharmaceutical Intermediate Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Pharmaceutical Intermediate Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Pharmaceutical Intermediate Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Pharmaceutical Intermediate Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Pharmaceutical Intermediate

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Pharmaceutical Intermediate by Different Types from 2014 to 2026

    • Table Consumption Share of Pharmaceutical Intermediate by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Type 1

    • Figure Market Size and Growth Rate of Type 2

    • Figure Market Size and Growth Rate of Type 3

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Pharmaceutical Intermediate by Different End-Users from 2014 to 2026

    • Table Consumption Share of Pharmaceutical Intermediate by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of End-User 1

    • Figure Market Size and Growth Rate of End-User 2

    • Figure Market Size and Growth Rate of End-User 3

    • Table Europe Pharmaceutical Intermediate Production by Major Regions

    • Table Europe Pharmaceutical Intermediate Production Share by Major Regions

    • Figure Europe Pharmaceutical Intermediate Production Share by Major Countries and Regions in 2014

    • Table Europe Pharmaceutical Intermediate Consumption by Major Regions

    • Table Europe Pharmaceutical Intermediate Consumption Share by Major Regions

    • Table Germany Pharmaceutical Intermediate Production, Import, Consumption and Export Analysis

    • Table UK Pharmaceutical Intermediate Production, Import, Consumption and Export Analysis

    • Table France Pharmaceutical Intermediate Production, Import, Consumption and Export Analysis

    • Table Italy Pharmaceutical Intermediate Production, Import, Consumption and Export Analysis

    • Table Spain Pharmaceutical Intermediate Production, Import, Consumption and Export Analysis

    • Table Poland Pharmaceutical Intermediate Production, Import, Consumption and Export Analysis

    • Table Russia Pharmaceutical Intermediate Production, Import, Consumption and Export Analysis

    • Table Switzerland Pharmaceutical Intermediate Production, Import, Consumption and Export Analysis

    • Table Turkey Pharmaceutical Intermediate Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Intermediate Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Intermediate Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Intermediate Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Pharmaceutical Intermediate Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Pharmaceutical Intermediate Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Pharmaceutical Intermediate Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Pharmaceutical Intermediate Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Pharmaceutical Intermediate Consumption by Types from 2014 to 2026

    • Table Germany Pharmaceutical Intermediate Consumption Share by Types from 2014 to 2026

    • Table Germany Pharmaceutical Intermediate Consumption by End-Users from 2014 to 2026

    • Table Germany Pharmaceutical Intermediate Consumption Share by End-Users from 2014 to 2026

    • Table UK Pharmaceutical Intermediate Consumption by Types from 2014 to 2026

    • Table UK Pharmaceutical Intermediate Consumption Share by Types from 2014 to 2026

    • Table UK Pharmaceutical Intermediate Consumption by End-Users from 2014 to 2026

    • Table UK Pharmaceutical Intermediate Consumption Share by End-Users from 2014 to 2026

    • Table France Pharmaceutical Intermediate Consumption by Types from 2014 to 2026

    • Table France Pharmaceutical Intermediate Consumption Share by Types from 2014 to 2026

    • Table France Pharmaceutical Intermediate Consumption by End-Users from 2014 to 2026

    • Table France Pharmaceutical Intermediate Consumption Share by End-Users from 2014 to 2026

    • Table Italy Pharmaceutical Intermediate Consumption by Types from 2014 to 2026

    • Table Italy Pharmaceutical Intermediate Consumption Share by Types from 2014 to 2026

    • Table Italy Pharmaceutical Intermediate Consumption by End-Users from 2014 to 2026

    • Table Italy Pharmaceutical Intermediate Consumption Share by End-Users from 2014 to 2026

    • Table Spain Pharmaceutical Intermediate Consumption by Types from 2014 to 2026

    • Table Spain Pharmaceutical Intermediate Consumption Share by Types from 2014 to 2026

    • Table Spain Pharmaceutical Intermediate Consumption by End-Users from 2014 to 2026

    • Table Spain Pharmaceutical Intermediate Consumption Share by End-Users from 2014 to 2026

    • Table Poland Pharmaceutical Intermediate Consumption by Types from 2014 to 2026

    • Table Poland Pharmaceutical Intermediate Consumption Share by Types from 2014 to 2026

    • Table Poland Pharmaceutical Intermediate Consumption by End-Users from 2014 to 2026

    • Table Poland Pharmaceutical Intermediate Consumption Share by End-Users from 2014 to 2026

    • Table Russia Pharmaceutical Intermediate Consumption by Types from 2014 to 2026

    • Table Russia Pharmaceutical Intermediate Consumption Share by Types from 2014 to 2026

    • Table Russia Pharmaceutical Intermediate Consumption by End-Users from 2014 to 2026

    • Table Russia Pharmaceutical Intermediate Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Pharmaceutical Intermediate Consumption by Types from 2014 to 2026

    • Table Switzerland Pharmaceutical Intermediate Consumption Share by Types from 2014 to 2026

    • Table Switzerland Pharmaceutical Intermediate Consumption by End-Users from 2014 to 2026

    • Table Switzerland Pharmaceutical Intermediate Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Pharmaceutical Intermediate Consumption by Types from 2014 to 2026

    • Table Turkey Pharmaceutical Intermediate Consumption Share by Types from 2014 to 2026

    • Table Turkey Pharmaceutical Intermediate Consumption by End-Users from 2014 to 2026

    • Table Turkey Pharmaceutical Intermediate Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Intermediate Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Intermediate Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Intermediate Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Intermediate Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Intermediate Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Intermediate Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Pharmaceutical Intermediate Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Pharmaceutical Intermediate Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Pharmaceutical Intermediate Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Pharmaceutical Intermediate Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Pharmaceutical Intermediate Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Intermediate Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Intermediate Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Intermediate Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Intermediate Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Intermediate Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Intermediate Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Pharmaceutical Intermediate Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Pharmaceutical Intermediate Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Pharmaceutical Intermediate Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Intermediate Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Intermediate Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Intermediate Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Intermediate Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Intermediate Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Intermediate Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Pharmaceutical Intermediate Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Pharmaceutical Intermediate Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Pharmaceutical Intermediate Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Arkema

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Arkema

    • Figure Sales and Growth Rate Analysis of Arkema

    • Figure Revenue and Market Share Analysis of Arkema

    • Table Product and Service Introduction of Arkema

    • Table Company Profile and Development Status of Arlife Sciences

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Arlife Sciences

    • Figure Sales and Growth Rate Analysis of Arlife Sciences

    • Figure Revenue and Market Share Analysis of Arlife Sciences

    • Table Product and Service Introduction of Arlife Sciences

    • Table Company Profile and Development Status of Kangda Chem

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kangda Chem

    • Figure Sales and Growth Rate Analysis of Kangda Chem

    • Figure Revenue and Market Share Analysis of Kangda Chem

    • Table Product and Service Introduction of Kangda Chem

    • Table Company Profile and Development Status of Dishman Group

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dishman Group

    • Figure Sales and Growth Rate Analysis of Dishman Group

    • Figure Revenue and Market Share Analysis of Dishman Group

    • Table Product and Service Introduction of Dishman Group

    • Table Company Profile and Development Status of Lianhe Tech

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lianhe Tech

    • Figure Sales and Growth Rate Analysis of Lianhe Tech

    • Figure Revenue and Market Share Analysis of Lianhe Tech

    • Table Product and Service Introduction of Lianhe Tech

    • Table Company Profile and Development Status of FST Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of FST Pharma

    • Figure Sales and Growth Rate Analysis of FST Pharma

    • Figure Revenue and Market Share Analysis of FST Pharma

    • Table Product and Service Introduction of FST Pharma

    • Table Company Profile and Development Status of Aceto

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aceto

    • Figure Sales and Growth Rate Analysis of Aceto

    • Figure Revenue and Market Share Analysis of Aceto

    • Table Product and Service Introduction of Aceto

    • Table Company Profile and Development Status of Interchem

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Interchem

    • Figure Sales and Growth Rate Analysis of Interchem

    • Figure Revenue and Market Share Analysis of Interchem

    • Table Product and Service Introduction of Interchem

    • Table Company Profile and Development Status of Codexis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Codexis

    • Figure Sales and Growth Rate Analysis of Codexis

    • Figure Revenue and Market Share Analysis of Codexis

    • Table Product and Service Introduction of Codexis

    • Table Company Profile and Development Status of Eastar Chem

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eastar Chem

    • Figure Sales and Growth Rate Analysis of Eastar Chem

    • Figure Revenue and Market Share Analysis of Eastar Chem

    • Table Product and Service Introduction of Eastar Chem

    • Table Company Profile and Development Status of BASF

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BASF

    • Figure Sales and Growth Rate Analysis of BASF

    • Figure Revenue and Market Share Analysis of BASF

    • Table Product and Service Introduction of BASF

    • Table Company Profile and Development Status of Midas Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Midas Pharma

    • Figure Sales and Growth Rate Analysis of Midas Pharma

    • Figure Revenue and Market Share Analysis of Midas Pharma

    • Table Product and Service Introduction of Midas Pharma

    • Table Company Profile and Development Status of Ganesh Group

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ganesh Group

    • Figure Sales and Growth Rate Analysis of Ganesh Group

    • Figure Revenue and Market Share Analysis of Ganesh Group

    • Table Product and Service Introduction of Ganesh Group

    • Table Company Profile and Development Status of Wintersun Chem

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Wintersun Chem

    • Figure Sales and Growth Rate Analysis of Wintersun Chem

    • Figure Revenue and Market Share Analysis of Wintersun Chem

    • Table Product and Service Introduction of Wintersun Chem

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US